Cancer Network: Survival Advantage Demonstrated With Higher-Dose Rhenium-186 Nanoliposome in Recurrent Glioma

<p>Andrew Brenner, MD, PhD, Medicine/Mays Cancer Center, is quoted in this article.   Read More</p>

Share This Story